IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 184 filers reported holding IMPAX LABORATORIES INC in Q2 2014. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $3,642,000 | +47.9% | 77,705 | 0.0% | 0.39% | +33.1% |
| Q4 2014 | $2,462,000 | -4.6% | 77,705 | -9.7% | 0.30% | +18.9% |
| Q2 2014 | $2,582,000 | +12.3% | 86,080 | -1.1% | 0.25% | +6.9% |
| Q1 2014 | $2,300,000 | +18.9% | 87,080 | +13.2% | 0.23% | +36.3% |
| Q4 2013 | $1,934,000 | – | 76,930 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |